# TRAW (Traws Pharma, Inc.) - SEC EDGAR Financial Statements

> Traws Pharma, Inc. reported $2.79M in revenue and a net loss of $22.31M for the fiscal year ended December 31, 2025 (up 1134.5% year over year), with a -798.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/TRAW
- Markdown: https://convexityos.com/fundamentals/TRAW.md
- SEC CIK: 0001130598
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001130598&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $2.79M | +1134.5% YoY |
| Operating Income | FY 2025 | -$22.28M | -798.7% margin |
| Net Income | FY 2025 | -$22.31M | -799.5% net margin |
| Diluted EPS | FY 2025 | -$1.31 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$20.77M | -744.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.79M | $226K | $226K | $226K | $226K | $231K | $2.18M | $1.23M | $787K | $5.55M |
| Research & Development | $12.14M | $12.85M | $11.43M | $11.41M | $7.30M | $16.90M | $15.54M | $16.92M | $19.12M | $20.07M |
| Total Operating Expenses | $20.66M | $142.6M | $20.52M | $19.85M | $16.72M | $25.22M | $23.88M | $24.51M | $26.52M | $29.25M |
| **Operating Income** | -$17.88M | -$142.4M | -$20.30M | -$19.63M | -$16.50M | -$24.99M | -$21.70M | -$23.28M | -$25.74M | -$23.70M |
| **EBITDA** | -$17.81M | -$142.4M | -$20.28M | -$19.61M | -$16.48M | -$24.98M | -$21.68M | -$23.23M | -$25.65M | -$23.61M |
| Interest Income | $455K | $510K | $1.39M | $651K | -- | -- | -- | -- | -- | -- |
| Income Before Tax | $9.17M | -$166.5M | -$18.95M | -$18.96M | -$16.16M | -$25.15M | -$21.49M | -$20.53M | -$24.08M | -$19.65M |
| Income Tax Expense | -- | -- | -- | -- | -- | $4.0K | $10K | -$124K | $13K | $14K |
| **Net Income** | $9.17M | -$166.5M | -$18.95M | -$18.96M | -$16.16M | -$25.16M | -$21.50M | -$20.57M | -$24.09M | -$19.67M |
| Basic EPS | $0.83 | -$35.21 | -$22.57 | -$22.75 | -$24.00 | -$54.25 | -$558.75 | -$1,871.25 | -$15,056.25 | -$24,975.00 |
| **Diluted EPS** | $0.82 | -$35.21 | -$22.57 | -$22.75 | -$24.00 | -$54.25 | -$558.75 | -$1,871.25 | -$15,056.25 | -$24,975.00 |
| Basic Shares Outstanding | 8.2M | 1.6M | 839.6K | 836.3K | 673.3K | 464.1K | 38.4K | 11.0K | 1.6K | 787 |
| Diluted Shares Outstanding | 8.4M | 1.6M | 839.6K | 836.3K | 673.3K | 464.1K | 38.4K | 11.0K | 1.6K | 787 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $2.73M | $57K | $56K |
| Research & Development | $1.83M | $2.29M | $4.91M | $5.04M | $2.31M | $2.29M | $2.51M | $1.86M |
| Total Operating Expenses | $3.60M | $4.37M | $6.95M | $7.37M | $4.05M | $3.98M | $5.26M | $5.33M |
| **Operating Income** | -$3.60M | -$4.37M | -$6.95M | -$7.37M | -$4.05M | -$1.25M | -$5.20M | -$5.28M |
| **EBITDA** | -$3.56M | -$4.32M | -$6.90M | -$7.32M | -$4.04M | -$1.25M | -$5.20M | -$5.28M |
| **Net Income** | -$3.55M | -$4.21M | -$7.11M | -$7.44M | -$3.96M | -$915K | $21.49M | -$29.92M |
| Basic EPS | -$0.18 | -$0.23 | -$0.53 | -- | -$0.34 | -$0.11 | $2.17 | -- |
| **Diluted EPS** | -$0.18 | -$0.23 | -$0.53 | -- | -$0.34 | -$0.11 | $2.09 | -- |
| Basic Shares Outstanding | 17.0M | 15.9M | 10.6M | -- | 8.8M | 5.8M | 7.0M | -- |
| Diluted Shares Outstanding | 17.0M | 15.9M | 10.6M | -- | 8.8M | 5.8M | 7.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $20.56M | $38.52M | -- | -- | -- | -- | -- | $21.40M |
| **Cash & Short-Term Investments** | -- | -- | $20.56M | $38.52M | -- | -- | -- | -- | -- | $21.40M |
| Accounts Receivable, Net | $3.79M | $1.76M | $18K | $29K | $28K | $37K | $98K | $35K | $59K | $31K |
| Other Current Assets | $89K | $178K | $401K | $40K | $35K | $180K | $140K | $68K | $77K | $73K |
| **Total Current Assets** | $7.98M | $24.95M | $22.66M | $39.35M | $55.43M | $19.78M | $23.47M | $17.77M | $4.90M | $23.07M |
| Property, Plant & Equipment, Net | $7.0K | $10K | $22K | $24K | $38K | $52K | $50K | $9.0K | $64K | $152K |
| Intangible Assets | $2.53M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $104K | $1.0K | $1.0K | $1.0K | $10K | $150K | $150K | $149K | $12K | $12K |
| **Total Non-Current Assets** | $2.64M | $11K | $23K | $25K | $48K | $202K | $200K | $158K | $76K | $164K |
| **Total Assets** | $10.62M | $24.96M | $22.68M | $39.37M | $55.48M | $19.99M | $23.67M | $17.92M | $4.98M | $23.23M |
| Accounts Payable | $5.65M | $8.19M | $5.62M | $3.86M | $2.76M | $4.83M | $4.27M | $4.04M | $6.19M | $5.32M |
| Deferred Revenue (Current) | -- | $226K | $226K | $226K | $226K | $226K | $226K | $226K | $455K | $455K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | $198K |
| **Total Current Liabilities** | $11.15M | $11.53M | $9.22M | $8.05M | $6.12M | $10.02M | $8.29M | $8.44M | $9.98M | $10.16M |
| Deferred Revenue (Non-Current) | -- | $2.56M | $2.79M | $3.02M | $3.24M | $3.47M | $3.69M | $3.92M | $4.09M | $4.54M |
| **Total Non-Current Liabilities** | $100K | $45.06M | $2.79M | $3.02M | $3.24M | $3.79M | $3.81M | $4.10M | $5.86M | $7.95M |
| **Total Liabilities** | $11.25M | $56.59M | $12.01M | $11.06M | $9.36M | $13.81M | $12.10M | $12.54M | $15.84M | $18.11M |
| Common Stock | $90K | $36K | $9.0K | $209K | $209K | $124K | $1.11M | $57K | $8.0K | $68K |
| Retained Earnings | -$640.0M | -$649.2M | -$482.6M | -$463.7M | -$444.7M | -$428.6M | -$403.4M | -$381.9M | -$362.3M | -$338.2M |
| Accumulated Other Comp. Income | $6.0K | -$42K | -$23K | -$33K | -$14K | $14K | -$18K | -$12K | $3.0K | -$31K |
| **Total Stockholders' Equity** | -- | -- | -- | -- | -- | -- | $11.57M | $5.39M | -$11.69M | $4.30M |
| Total Equity | -$629K | -$31.63M | $10.67M | $28.31M | $46.12M | $6.17M | $11.57M | $5.39M | -$10.86M | $5.13M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Accounts Receivable, Net | $2.19M | $2.30M | $1.69M | $3.79M | $1.99M | $1.32M | $1.65M | $1.76M |
| Other Current Assets | $92K | $93K | $138K | $89K | $92K | $124K | $183K | $178K |
| **Total Current Assets** | $4.98M | $7.87M | $5.67M | $7.98M | $9.62M | $15.37M | $18.86M | $24.95M |
| Property, Plant & Equipment, Net | $5.0K | $5.0K | $6.0K | $7.0K | $7.0K | $8.0K | $9.0K | $10K |
| Intangible Assets | $2.40M | $2.44M | $2.48M | $2.53M | $2.57M | -- | -- | -- |
| Other Non-Current Assets | $142K | $1.0K | $1.0K | $104K | $240K | $244K | $198K | $1.0K |
| **Total Non-Current Assets** | $2.54M | $2.45M | $2.49M | $2.64M | $2.82M | $252K | $207K | $11K |
| **Total Assets** | $7.52M | $10.31M | $8.16M | $10.62M | $12.44M | $15.62M | $19.06M | $24.96M |
| Accounts Payable | $6.65M | $6.33M | $7.67M | $5.65M | $5.11M | $4.76M | $7.66M | $8.19M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | $226K | $226K |
| **Total Current Liabilities** | $9.64M | $9.73M | $13.21M | $11.15M | $7.89M | $7.35M | $10.40M | $11.53M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $2.51M | $2.56M |
| **Total Non-Current Liabilities** | $8.0K | $44K | $259K | $100K | $11K | $8.0K | $2.66M | $45.06M |
| **Total Liabilities** | $9.65M | $9.78M | $13.47M | $11.25M | $7.90M | $7.36M | $13.06M | $56.59M |
| Common Stock | $153K | $152K | $101K | $90K | $71K | $71K | $50K | $36K |
| Retained Earnings | -$654.8M | -$651.3M | -$647.1M | -$640.0M | -$632.5M | -$628.6M | -$627.7M | -$649.2M |
| Accumulated Other Comp. Income | -$7.0K | -$5.0K | -$2.0K | $6.0K | $6.0K | $9.0K | -$19K | -$42K |
| Total Equity | -$2.13M | $535K | -$5.31M | -$629K | $4.54M | $8.26M | $6.00M | -$31.63M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $9.17M | -$166.5M | -$18.95M | -$18.96M | -$16.16M | -$25.16M | -$21.50M | -$20.41M | -$24.09M | -$19.67M |
| Depreciation & Amortization | $61K | $12K | $16K | $14K | $14K | $13K | $14K | $55K | $88K | $96K |
| Stock-Based Compensation | $728K | $1.39M | $1.30M | $1.17M | $576K | $369K | $1.05M | $1.15M | $1.71M | $3.93M |
| Change in Receivables | -$2.03M | -$1.75M | $11K | -$1.0K | $9.0K | $61K | -$63K | $24K | -$28K | $1.47M |
| Change in Payables | -$612K | $646K | $1.76M | $1.10M | -$2.08M | $562K | $232K | -$1.45M | $863K | $1.90M |
| **Operating Cash Flow** | -$18.18M | -$29.79M | -$17.93M | -$16.29M | -$19.49M | -$23.07M | -$20.83M | -$22.70M | -$23.82M | -$15.81M |
| Capital Expenditure | -$2.58M | -$3.65M | -$14K | -- | -- | -$15K | -$55K | -- | -- | -- |
| **Free Cash Flow** | -$20.77M | -$33.44M | -$17.95M | -- | -- | -$23.09M | -$20.89M | -- | -- | -- |
| **Investing Cash Flow** | -$2.58M | -$3.65M | -$14K | -- | -- | -$15K | -$55K | -- | -- | -- |
| Common Stock Issued | $5.58M | -- | -- | -- | $55.04M | $9.06M | $21.76M | $35.07M | -- | -- |
| **Financing Cash Flow** | $3.20M | $33.98M | -- | -- | $55.56M | $19.36M | $26.65M | $35.66M | $6.36M | $17.42M |
| **Net Change in Cash** | -$17.52M | $517K | -$17.94M | -$16.31M | $36.05M | -$3.70M | $5.76M | $12.95M | -$17.43M | $1.60M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.70M | -$3.05M | -$7.11M | -$7.44M | -$3.96M | -$915K | $21.49M | -$29.92M |
| Depreciation & Amortization | $43K | $44K | $44K | $44K | $15K | $1.0K | $1.0K | $2.0K |
| Stock-Based Compensation | $795K | $816K | $634K | $327K | $135K | $105K | $161K | $334K |
| Change in Receivables | $3.10M | -$3.60M | $2.11M | -$1.80M | -$668K | $331K | $111K | -- |
| Change in Payables | $464K | -$1.48M | $2.01M | $2.47M | $524K | -$3.00M | -$605K | $793K |
| **Operating Cash Flow** | -$2.48M | -$7.50M | -$2.58M | -$2.76M | -$4.01M | -$5.98M | -$5.44M | -$4.04M |
| Common Stock Issued | $91K | $120K | $1.90M | $2.09M | $116K | $3.26M | $122K | -- |
| **Financing Cash Flow** | -$197K | $9.39M | $1.90M | $158K | -$62K | $3.10M | $13K | -- |
| **Net Change in Cash** | -$2.68M | $1.88M | -$687K | -$2.60M | -$6.66M | -$2.86M | -$5.40M | $15.93M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -640.7% | -62997.3% | -8981.4% | -8684.5% | -7299.1% | -10819.5% | -994.0% | -1895.9% | -3270.3% | -427.4% |
| **Net Profit Margin** | 328.7% | -73682.7% | -8384.1% | -8391.2% | -7151.8% | -10890.5% | -985.0% | -1675.3% | -3061.2% | -354.6% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -185.8% | -381.9% | -- | -457.7% |
| Return on Assets (ROA) | 86.4% | -667.1% | -83.5% | -48.2% | -29.1% | -125.9% | -90.8% | -114.8% | -483.9% | -84.7% |
| Current Ratio | 0.72x | 2.16x | 2.46x | 4.89x | 9.06x | 1.97x | 2.83x | 2.11x | 0.49x | 2.27x |
| Quick Ratio | -- | -- | 2.23x | 4.79x | -- | -- | -- | -- | -- | 2.11x |
| **Revenue Growth (YoY)** | +1134.5% | 0.0% | 0.0% | 0.0% | -2.2% | -89.4% | +77.8% | +56.0% | -85.8% | -51.6% |
| 5Y Revenue / Share Growth | -31.9% | -99.7% | -99.8% | -99.9% | -100.0% | -100.0% | -97.3% | -99.6% | -100.0% | -82.0% |
| 10Y Revenue / Share Growth | -100.0% | -100.0% | -100.0% | -100.0% | -100.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -640.7% | -554.6% | -698.1% | -62715.9% | -62997.3% |
| **Net Profit Margin** | -- | -- | -- | 328.7% | -467.6% | -613.9% | -61696.0% | -73682.7% |
| Return on Assets (ROA) | -296.6% | -220.3% | -238.2% | 86.4% | -107.0% | -114.1% | -734.7% | -667.1% |
| Current Ratio | 0.52x | 0.81x | 0.43x | 0.72x | 1.22x | 2.09x | 1.81x | 2.16x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -100.0% | +4694.7% | +1.8% | 0.0% |
| **Net Income Growth (YoY)** | -- | -- | -133.1% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -124.4% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
